{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T05:02:11Z","timestamp":1749358931603},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jocn.2024.05.008","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T02:45:26Z","timestamp":1715913926000},"page":"95-96","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration"],"prefix":"10.1016","volume":"125","author":[{"given":"Prateek Kumar","family":"Panda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indar Kumar","family":"Sharawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.05.008_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jocn.2024.04.021","article-title":"Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study","volume":"124","author":"Sai Folmsbee","year":"2024","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2024.05.008_b0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2522\/ptj.20130149","article-title":"Outcome measures for individuals with multiple sclerosis: recommendations from the American Physical Therapy Association Neurology Section task force","volume":"94","author":"Potter","year":"2014","journal-title":"Phys Ther"},{"key":"10.1016\/j.jocn.2024.05.008_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.braindev.2022.09.009","article-title":"Validity and prognostic utility of clinical assessment scale for autoimmune encephalitis (CASE) score in children with autoimmune encephalitis","volume":"45","author":"Panda","year":"2023","journal-title":"Brain Dev"},{"key":"10.1016\/j.jocn.2024.05.008_b0020","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/acn3.51865","article-title":"Clinical scales in autoimmune encephalitis\u2014A retrospective monocentric cohort study","volume":"10","author":"Macher","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jocn.2024.05.008_b0025","first-page":"77","article-title":"Positive and Negative Syndrome Scale (PANSS) Training","volume":"14","author":"Opler","year":"2017","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.jocn.2024.05.008_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.37737\/ace.22005","article-title":"Introduction to Matching in Case-Control and Cohort Studies","volume":"4","author":"Iwagami","year":"2022","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.jocn.2024.05.008_b0035","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/brain\/awac166","article-title":"Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes","volume":"145","author":"Lee","year":"2022","journal-title":"Brain"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T01:03:25Z","timestamp":1717635805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":7,"alternative-id":["S0967586824001875"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.05.008","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}